Triple Positive Oral Squamous Cell Carcinoma Patients Predict Poor Survival Outcomes: Multiple Factor Positivity Warrants the Need for Modified Treatment Approaches-Reference-Cited by-同舟云学术

Triple Positive Oral Squamous Cell Carcinoma Patients Predict Poor Survival Outcomes: Multiple Factor Positivity Warrants the Need for Modified Treatment Approaches

Published:2024-04-29 Issue:4 Volume:23 Page:923-934
ISSN:0972-8279
Container-title:Journal of Maxillofacial and Oral Surgery
language:en
Short-container-title:J. Maxillofac. Oral Surg.

Author:

Jain Priyansh,Sultania Mahesh^ORCID,Muduly Dillip,Chaudhary Itisha,Ghalige Hemanth,Patro Sangram,Adhya Amit,Kar Madhabananda

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12663-024-02186-5.pdf

Reference35 articles.

1. Braakhuis BJM, Leemans CR, Visser O (2014) Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol 50:670–675. https://doi.org/10.1016/j.oraloncology.2014.03.008

2. Dolens ED, Dourado MR, Almangush A, Salo TA, Gurgel Rocha CA, da Silva SD, Brennan PA, Coletta RD (2021) The impact of histopathological features on the prognosis of oral squamous cell carcinoma: a comprehensive review and meta-analysis. Front Oncol 10(11):784924. https://doi.org/10.3389/fonc.2021.784924

3. Mascitti M, Togni L, Caponio VCA, Zhurakivska K, Bizzoca ME, Contaldo M et al (2022) Lymphovascular invasion as a prognostic tool for oral squamous cell carcinoma: a comprehensive review. Int J Oral Maxillofac Surg 51:1–9. https://doi.org/10.1016/j.ijom.2021.03.007

4. Chatzistefanou I, Lubek J, Markou K, Ord RA (2017) The role of perineural invasion in treatment decisions for oral cancer patients: a review of the literature. J Cranio-Maxillofac Surg 45:821–825. https://doi.org/10.1016/j.jcms.2017.02.022

5. Chen WC, Lai CH, Fang CC, Yang YH, Chen PC, Lee CP et al (2016) Identification of high-risk subgroups of patients with oral cavity cancer in need of postoperative adjuvant radiotherapy or chemo-radiotherapy. Medicine 95:1–8. https://doi.org/10.1097/MD.0000000000003770